Related references
Note: Only part of the references are listed.Characterization of biomolecular nanoconjugates by high-throughput delivery and spectroscopic difference
Robert K. DeLong et al.
NANOMEDICINE (2012)
A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment
Yangqing Zhang et al.
ACTA BIOMATERIALIA (2010)
The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity
Fei Yan et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment
Yuandong Ma et al.
NANOSCALE RESEARCH LETTERS (2010)
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel
Si-Shen Feng et al.
BIOMATERIALS (2009)
Thiolated Chitosan Nanoparticles as an Oral Delivery System for Amikacin: In Vitro and Ex Vivo Evaluations
F. Atyabi et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2009)
A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment
Lin Mei et al.
NANOSCALE RESEARCH LETTERS (2009)
PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat
V. Bhardwaj et al.
PHARMACEUTICAL RESEARCH (2009)
Current status and future prospects for satraplatin, an oral platinum analogue
Hak Choy et al.
CLINICAL CANCER RESEARCH (2008)
Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
Constantina Constantinou et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Vitamin E analogs, a novel group of mitocans, as anticancer agents: The importance of being redox-silent
Jiri Neuzil et al.
MOLECULAR PHARMACOLOGY (2007)
Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model
Lin Mei et al.
PHARMACEUTICAL RESEARCH (2007)
Nanoparticle interaction with biological membranes: Does nanotechnology present a janus face?
Pascale R. Leroueil et al.
ACCOUNTS OF CHEMICAL RESEARCH (2007)
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
Anne des Rieux et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy
S Hariharan et al.
PHARMACEUTICAL RESEARCH (2006)
Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol
HJ Youk et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Nano-encapsulation of azole antifungals: Potential applications to improve oral drug delivery
R Pandey et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093)
IELM Kuppens et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
SA Agnihotri et al.
JOURNAL OF CONTROLLED RELEASE (2004)
HIV-1 protease inhibitor, ritonavir:: A potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo
T Ikezoe et al.
CANCER RESEARCH (2004)
Thiolated polymers-thiomers:: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates
A Bernkop-Schnürch et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole
CE Kast et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells
M Hasegawa et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Share Paper
